Parcourir par sujet "Prostatic Hyperplasia"

The impact of combination therapy with a-blockers and 5ARIs on the progression of BPH

Sountoulides P., Gravas S. (2015)

Benign prostatic hyperplasia (BPH) can be a progressive disease for some men with significant impact on their quality of life due to worsening of symptoms, risk of acute urinary retention (AUR) and surgery. Certain clinical ...

Management of Urinary Retention in Patients with Benign Prostatic Obstruction: A Systematic Review and Meta-analysis

Karavitakis M., Kyriazis I., Omar M.I., Gravas S., Cornu J.-N., Drake M.J., Gacci M., Gratzke C., Herrmann T.R.W., Madersbacher S., Rieken M., Speakman M.J., Tikkinen K.A.O., Yuan Y., Mamoulakis C. (2019)

Context: Practice patterns for the management of urinary retention (UR) secondary to benign prostatic obstruction (BPO; UR/BPO) vary widely and remain unstandardized. Objective: To review the evidence for managing patients ...

Mind the gap: management of benign prostatic obstruction (BPO) surgical candidates on antithrombotics

Dimitropoulos K., Gravas S. (2020)

[No abstract available]

Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome

Sebastianelli A., Morselli S., Spatafora P., Liaci A., Gemma L., Zaccaro C., Vignozzi L., Maggi M., McVary K.T., Kaplan S.A., Chapple C., Gravas S., Serni S., Gacci M. (2022)

BACKGROUND: The aim of this study was to assess the impact of tadalafil 5 mg/die plus tamsulosin 0.4 mg/die combination therapy on lower urinary tract symptoms (LUTS) and erectile dysfunction (ED), according to presence ...

Practice patterns in diagnosis and treatment of lower urinary tract symptoms due to benign prostatic hyperplasia among general practitioners: Lessons learnt from a Greek survey

Samarinas M., Moysidis K., Perdikaki P., Gravas S. (2018)

[No abstract available]

Preservation of antegrade ejaculation after surgical relief of benign prostatic obstruction is a valid endpoint

Calik G., Laguna M.P., Gravas S., Albayrak S., de la Rosette J. (2021)

Purpose: To review the current data on retrograde ejaculation (RE) and ejaculatory dysfunction (EjD) after endoscopic and minimally invasive surgical treatment of benign prostatic obstruction (BPO) and, their perceived ...

Prostate Volume as a Risk Factor for Lower Urinary Tract Symptoms: The Quest Continues

Gravas S. (2016)

[No abstract available]

Tadalafil Alone or in Combination with Tamsulosin for the Management for LUTS/BPH and ED

Sebastianelli A., Spatafora P., Morselli S., Vignozzi L., Serni S., McVary K.T., Kaplan S., Gravas S., Chapple C., Gacci M. (2020)

Purpose of Review: Aim of our systematic review is to evaluate and summarize the efficacy and safety of tadalafil alone or in combination with tamsulosin for the management of lower urinary tract symptoms (LUTS)/benign ...

TURPxit or not: the guidelines perspective—Panta Rhei

Gravas S. (2021)

[No abstract available]

What Is the Required Certainty of Evidence for the Implementation of Novel Techniques for the Treatment of Benign Prostatic Obstruction?

Speakman M.J., Cornu J.-N., Gacci M., Gratzke C., Mamoulakis C., Herrmann T.R.W., Omar M.I., Rieken M., Tikkinen K.A.O., Gravas S. (2019)

Context: A large number of minimally invasive techniques have been developed for the surgical management of male lower urinary tract symptoms (LUTS) presumed to be secondary to benign prostatic obstruction (BPO) over the ...

Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial

Sebastianelli A., Spatafora P., Frizzi J., Saleh O., De Nunzio C., Tubaro A., Vignozzi L., Maggi M., Serni S., McVary K.T., Kaplan S.A., Gravas S., Chapple C., Gacci M. (2021)

Background: Safety and efficacy of tamsulosin and tadalafil for men with benign prostatic enlargement (BPE) and/or erectile dysfunction (ED) are defined. However, there are only a few pilot studies on combination therapy ...